CLINICAL_TRIALS
trial_result
· 2015-06-10
Clinical Trial Update: Iron Sucrose In The Treatment of Restless Legs Syndrome: Safety of Three Dose Regimens as Evaluated by Clinical Assessments [Phase 2]
Summary
Phase 2 trial assessing the safety of three dose regimens of iron sucrose for Restless Legs Syndrome based on clinical assessments.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: American Regent, Inc. | Conditions: Restless Legs Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2015-06-10